お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ヘキサデカナミドの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にヘキサデカナミド市場を分類しています。
本レポートでは世界のヘキサデカナミド市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Shengrui Medicine、Hangzhou Fanda Chemical、Changzhou Kefeng、Shalong Chemical、Phosgene Chemical、Ditong Chemical、BASF

レポートはヘキサデカナミドの主要生産者を調査し、主要地域や国の消費状況も提供します。ヘキサデカナミドの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Purity 95%
    Purity 99%
    Others

用途別の市場セグメント：
    Pharmaceutical Intermediates
    Cosmetic Additives
    Others

本レポートの詳細内容
本レポートは、世界のヘキサデカナミド市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてヘキサデカナミド市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のヘキサデカナミド生産量、成長率、市場シェアを調査している。

二. 消費面では、ヘキサデカナミドの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのヘキサデカナミド売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のヘキサデカナミド市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ヘキサデカナミドのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ヘキサデカナミドのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： ヘキサデカナミドの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるヘキサデカナミドの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章ヘキサデカナミドメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：ヘキサデカナミドの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：ヘキサデカナミドの主要メーカーの概要を提供し、製品の説明と仕様、ヘキサデカナミドの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ヘキサデカナミドの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Hexadecanamide is a fatty acid amide.

The global Hexadecanamide market is projected to grow from US$ 91 million in 2024 to US$ 111.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Chemical is an important driver of this industry. Emerging economies, particularly in Asia and Latin America, are experiencing rapid industrialization, urbanization, and population growth. This drives the demand for bulk chemicals across various sectors, including construction, automotive, electronics, agriculture, and consumer goods. The rising middle class in these regions is also contributing to increased consumption of chemical products.
In terms of production side, this report researches the Hexadecanamide production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Hexadecanamide by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Hexadecanamide, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Hexadecanamide, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Hexadecanamide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hexadecanamide sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hexadecanamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hexadecanamide sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Shengrui Medicine
    Hangzhou Fanda Chemical
    Changzhou Kefeng
    Shalong Chemical
    Phosgene Chemical
    Ditong Chemical
    BASF

Segment by Type
    Purity 95%
    Purity 99%
    Others

Segment by Application
    Pharmaceutical Intermediates
    Cosmetic Additives
    Others

Production by Region
    North America
    Europe
    China
    Japan

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Hexadecanamide production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Hexadecanamide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Hexadecanamide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hexadecanamide sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

List of Tables
    Table 1. Global Hexadecanamide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Purity 95%
    Table 3. Major Manufacturers of Purity 99%
    Table 4. Major Manufacturers of Others
    Table 5. Global Hexadecanamide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Hexadecanamide Production by Region: 2019 VS 2023 VS 2030 (MT)
    Table 7. Global Hexadecanamide Production by Region (2019-2024) & (MT)
    Table 8. Global Hexadecanamide Production by Region (2025-2030) & (MT)
    Table 9. Global Hexadecanamide Production Market Share by Region (2019-2024)
    Table 10. Global Hexadecanamide Production Market Share by Region (2025-2030)
    Table 11. Global Hexadecanamide Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Hexadecanamide Revenue by Region (2019-2024) & (US$ Million)
    Table 13. Global Hexadecanamide Revenue by Region (2025-2030) & (US$ Million)
    Table 14. Global Hexadecanamide Revenue Market Share by Region (2019-2024)
    Table 15. Global Hexadecanamide Revenue Market Share by Region (2025-2030)
    Table 16. Global Hexadecanamide Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Hexadecanamide Sales by Region (2019-2024) & (MT)
    Table 18. Global Hexadecanamide Sales by Region (2025-2030) & (MT)
    Table 19. Global Hexadecanamide Sales Market Share by Region (2019-2024)
    Table 20. Global Hexadecanamide Sales Market Share by Region (2025-2030)
    Table 21. Global Hexadecanamide Sales by Manufacturers (2019-2024) & (MT)
    Table 22. Global Hexadecanamide Sales Share by Manufacturers (2019-2024)
    Table 23. Global Hexadecanamide Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 24. Global Hexadecanamide Revenue Share by Manufacturers (2019-2024)
    Table 25. Hexadecanamide Price by Manufacturers 2019-2024 (USD/MT)
    Table 26. Global Key Players of Hexadecanamide, Industry Ranking, 2022 VS 2023 VS 2024
    Table 27. Global Hexadecanamide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 28. Global Hexadecanamide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hexadecanamide as of 2023)
    Table 29. Global Key Manufacturers of Hexadecanamide, Manufacturing Base Distribution and Headquarters
    Table 30. Global Key Manufacturers of Hexadecanamide, Product Offered and Application
    Table 31. Global Key Manufacturers of Hexadecanamide, Date of Enter into This Industry
    Table 32. Mergers & Acquisitions, Expansion Plans
    Table 33. Global Hexadecanamide Sales by Type (2019-2024) & (MT)
    Table 34. Global Hexadecanamide Sales by Type (2025-2030) & (MT)
    Table 35. Global Hexadecanamide Sales Share by Type (2019-2024)
    Table 36. Global Hexadecanamide Sales Share by Type (2025-2030)
    Table 37. Global Hexadecanamide Revenue by Type (2019-2024) & (US$ Million)
    Table 38. Global Hexadecanamide Revenue by Type (2025-2030) & (US$ Million)
    Table 39. Global Hexadecanamide Revenue Share by Type (2019-2024)
    Table 40. Global Hexadecanamide Revenue Share by Type (2025-2030)
    Table 41. Hexadecanamide Price by Type (2019-2024) & (USD/MT)
    Table 42. Global Hexadecanamide Price Forecast by Type (2025-2030) & (USD/MT)
    Table 43. Global Hexadecanamide Sales by Application (2019-2024) & (MT)
    Table 44. Global Hexadecanamide Sales by Application (2025-2030) & (MT)
    Table 45. Global Hexadecanamide Sales Share by Application (2019-2024)
    Table 46. Global Hexadecanamide Sales Share by Application (2025-2030)
    Table 47. Global Hexadecanamide Revenue by Application (2019-2024) & (US$ Million)
    Table 48. Global Hexadecanamide Revenue by Application (2025-2030) & (US$ Million)
    Table 49. Global Hexadecanamide Revenue Share by Application (2019-2024)
    Table 50. Global Hexadecanamide Revenue Share by Application (2025-2030)
    Table 51. Hexadecanamide Price by Application (2019-2024) & (USD/MT)
    Table 52. Global Hexadecanamide Price Forecast by Application (2025-2030) & (USD/MT)
    Table 53. US & Canada Hexadecanamide Sales by Type (2019-2024) & (MT)
    Table 54. US & Canada Hexadecanamide Sales by Type (2025-2030) & (MT)
    Table 55. US & Canada Hexadecanamide Revenue by Type (2019-2024) & (US$ Million)
    Table 56. US & Canada Hexadecanamide Revenue by Type (2025-2030) & (US$ Million)
    Table 57. US & Canada Hexadecanamide Sales by Application (2019-2024) & (MT)
    Table 58. US & Canada Hexadecanamide Sales by Application (2025-2030) & (MT)
    Table 59. US & Canada Hexadecanamide Revenue by Application (2019-2024) & (US$ Million)
    Table 60. US & Canada Hexadecanamide Revenue by Application (2025-2030) & (US$ Million)
    Table 61. US & Canada Hexadecanamide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 62. US & Canada Hexadecanamide Revenue by Country (2019-2024) & (US$ Million)
    Table 63. US & Canada Hexadecanamide Revenue by Country (2025-2030) & (US$ Million)
    Table 64. US & Canada Hexadecanamide Sales by Country (2019-2024) & (MT)
    Table 65. US & Canada Hexadecanamide Sales by Country (2025-2030) & (MT)
    Table 66. Europe Hexadecanamide Sales by Type (2019-2024) & (MT)
    Table 67. Europe Hexadecanamide Sales by Type (2025-2030) & (MT)
    Table 68. Europe Hexadecanamide Revenue by Type (2019-2024) & (US$ Million)
    Table 69. Europe Hexadecanamide Revenue by Type (2025-2030) & (US$ Million)
    Table 70. Europe Hexadecanamide Sales by Application (2019-2024) & (MT)
    Table 71. Europe Hexadecanamide Sales by Application (2025-2030) & (MT)
    Table 72. Europe Hexadecanamide Revenue by Application (2019-2024) & (US$ Million)
    Table 73. Europe Hexadecanamide Revenue by Application (2025-2030) & (US$ Million)
    Table 74. Europe Hexadecanamide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 75. Europe Hexadecanamide Revenue by Country (2019-2024) & (US$ Million)
    Table 76. Europe Hexadecanamide Revenue by Country (2025-2030) & (US$ Million)
    Table 77. Europe Hexadecanamide Sales by Country (2019-2024) & (MT)
    Table 78. Europe Hexadecanamide Sales by Country (2025-2030) & (MT)
    Table 79. China Hexadecanamide Sales by Type (2019-2024) & (MT)
    Table 80. China Hexadecanamide Sales by Type (2025-2030) & (MT)
    Table 81. China Hexadecanamide Revenue by Type (2019-2024) & (US$ Million)
    Table 82. China Hexadecanamide Revenue by Type (2025-2030) & (US$ Million)
    Table 83. China Hexadecanamide Sales by Application (2019-2024) & (MT)
    Table 84. China Hexadecanamide Sales by Application (2025-2030) & (MT)
    Table 85. China Hexadecanamide Revenue by Application (2019-2024) & (US$ Million)
    Table 86. China Hexadecanamide Revenue by Application (2025-2030) & (US$ Million)
    Table 87. Asia Hexadecanamide Sales by Type (2019-2024) & (MT)
    Table 88. Asia Hexadecanamide Sales by Type (2025-2030) & (MT)
    Table 89. Asia Hexadecanamide Revenue by Type (2019-2024) & (US$ Million)
    Table 90. Asia Hexadecanamide Revenue by Type (2025-2030) & (US$ Million)
    Table 91. Asia Hexadecanamide Sales by Application (2019-2024) & (MT)
    Table 92. Asia Hexadecanamide Sales by Application (2025-2030) & (MT)
    Table 93. Asia Hexadecanamide Revenue by Application (2019-2024) & (US$ Million)
    Table 94. Asia Hexadecanamide Revenue by Application (2025-2030) & (US$ Million)
    Table 95. Asia Hexadecanamide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 96. Asia Hexadecanamide Revenue by Region (2019-2024) & (US$ Million)
    Table 97. Asia Hexadecanamide Revenue by Region (2025-2030) & (US$ Million)
    Table 98. Asia Hexadecanamide Sales by Region (2019-2024) & (MT)
    Table 99. Asia Hexadecanamide Sales by Region (2025-2030) & (MT)
    Table 100. Middle East, Africa and Latin America Hexadecanamide Sales by Type (2019-2024) & (MT)
    Table 101. Middle East, Africa and Latin America Hexadecanamide Sales by Type (2025-2030) & (MT)
    Table 102. Middle East, Africa and Latin America Hexadecanamide Revenue by Type (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Hexadecanamide Revenue by Type (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Hexadecanamide Sales by Application (2019-2024) & (MT)
    Table 105. Middle East, Africa and Latin America Hexadecanamide Sales by Application (2025-2030) & (MT)
    Table 106. Middle East, Africa and Latin America Hexadecanamide Revenue by Application (2019-2024) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Hexadecanamide Revenue by Application (2025-2030) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Hexadecanamide Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 109. Middle East, Africa and Latin America Hexadecanamide Revenue by Country (2019-2024) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Hexadecanamide Revenue by Country (2025-2030) & (US$ Million)
    Table 111. Middle East, Africa and Latin America Hexadecanamide Sales by Country (2019-2024) & (MT)
    Table 112. Middle East, Africa and Latin America Hexadecanamide Sales by Country (2025-2030) & (MT)
    Table 113. Shengrui Medicine Company Information
    Table 114. Shengrui Medicine Description and Major Businesses
    Table 115. Shengrui Medicine Hexadecanamide Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 116. Shengrui Medicine Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Shengrui Medicine Recent Development
    Table 118. Hangzhou Fanda Chemical Company Information
    Table 119. Hangzhou Fanda Chemical Description and Major Businesses
    Table 120. Hangzhou Fanda Chemical Hexadecanamide Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 121. Hangzhou Fanda Chemical Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Hangzhou Fanda Chemical Recent Development
    Table 123. Changzhou Kefeng Company Information
    Table 124. Changzhou Kefeng Description and Major Businesses
    Table 125. Changzhou Kefeng Hexadecanamide Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 126. Changzhou Kefeng Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Changzhou Kefeng Recent Development
    Table 128. Shalong Chemical Company Information
    Table 129. Shalong Chemical Description and Major Businesses
    Table 130. Shalong Chemical Hexadecanamide Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 131. Shalong Chemical Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Shalong Chemical Recent Development
    Table 133. Phosgene Chemical Company Information
    Table 134. Phosgene Chemical Description and Major Businesses
    Table 135. Phosgene Chemical Hexadecanamide Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 136. Phosgene Chemical Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Phosgene Chemical Recent Development
    Table 138. Ditong Chemical Company Information
    Table 139. Ditong Chemical Description and Major Businesses
    Table 140. Ditong Chemical Hexadecanamide Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 141. Ditong Chemical Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Ditong Chemical Recent Development
    Table 143. BASF Company Information
    Table 144. BASF Description and Major Businesses
    Table 145. BASF Hexadecanamide Capacity Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 146. BASF Hexadecanamide Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. BASF Recent Development
    Table 148. Key Raw Materials Lists
    Table 149. Raw Materials Key Suppliers Lists
    Table 150. Hexadecanamide Distributors List
    Table 151. Hexadecanamide Customers List
    Table 152. Hexadecanamide Market Trends
    Table 153. Hexadecanamide Market Drivers
    Table 154. Hexadecanamide Market Challenges
    Table 155. Hexadecanamide Market Restraints
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hexadecanamide Product Picture
    Figure 2. Global Hexadecanamide Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Hexadecanamide Market Share by Type in 2023 & 2030
    Figure 4. Purity 95% Product Picture
    Figure 5. Purity 99% Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Hexadecanamide Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Hexadecanamide Market Share by Application in 2023 & 2030
    Figure 9. Pharmaceutical Intermediates
    Figure 10. Cosmetic Additives
    Figure 11. Others
    Figure 12. Hexadecanamide Report Years Considered
    Figure 13. Global Hexadecanamide Capacity, Production and Utilization (2019-2030) & (MT)
    Figure 14. Global Hexadecanamide Production Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Hexadecanamide Production Market Share by Region (2019-2030)
    Figure 16. Hexadecanamide Production Growth Rate in North America (2019-2030) & (MT)
    Figure 17. Hexadecanamide Production Growth Rate in Europe (2019-2030) & (MT)
    Figure 18. Hexadecanamide Production Growth Rate in China (2019-2030) & (MT)
    Figure 19. Hexadecanamide Production Growth Rate in Japan (2019-2030) & (MT)
    Figure 20. Global Hexadecanamide Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 21. Global Hexadecanamide Revenue 2019-2030 (US$ Million)
    Figure 22. Global Hexadecanamide Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Figure 23. Global Hexadecanamide Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 24. Global Hexadecanamide Revenue Market Share by Region (2019-2030)
    Figure 25. Global Hexadecanamide Sales 2019-2030 ((MT)
    Figure 26. Global Hexadecanamide Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (MT)
    Figure 27. Global Hexadecanamide Sales Market Share by Region (2019-2030)
    Figure 28. US & Canada Hexadecanamide Sales YoY (2019-2030) & (MT)
    Figure 29. US & Canada Hexadecanamide Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Hexadecanamide Sales YoY (2019-2030) & (MT)
    Figure 31. Europe Hexadecanamide Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. China Hexadecanamide Sales YoY (2019-2030) & (MT)
    Figure 33. China Hexadecanamide Revenue YoY (2019-2030) & (US$ Million)
    Figure 34. Asia (excluding China) Hexadecanamide Sales YoY (2019-2030) & (MT)
    Figure 35. Asia (excluding China) Hexadecanamide Revenue YoY (2019-2030) & (US$ Million)
    Figure 36. Middle East, Africa and Latin America Hexadecanamide Sales YoY (2019-2030) & (MT)
    Figure 37. Middle East, Africa and Latin America Hexadecanamide Revenue YoY (2019-2030) & (US$ Million)
    Figure 38. The Hexadecanamide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 39. The Top 5 and 10 Largest Manufacturers of Hexadecanamide in the World: Market Share by Hexadecanamide Revenue in 2023
    Figure 40. Global Hexadecanamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 41. Global Hexadecanamide Sales Market Share by Type (2019-2030)
    Figure 42. Global Hexadecanamide Revenue Market Share by Type (2019-2030)
    Figure 43. Global Hexadecanamide Sales Market Share by Application (2019-2030)
    Figure 44. Global Hexadecanamide Revenue Market Share by Application (2019-2030)
    Figure 45. US & Canada Hexadecanamide Sales Market Share by Type (2019-2030)
    Figure 46. US & Canada Hexadecanamide Revenue Market Share by Type (2019-2030)
    Figure 47. US & Canada Hexadecanamide Sales Market Share by Application (2019-2030)
    Figure 48. US & Canada Hexadecanamide Revenue Market Share by Application (2019-2030)
    Figure 49. US & Canada Hexadecanamide Revenue Share by Country (2019-2030)
    Figure 50. US & Canada Hexadecanamide Sales Share by Country (2019-2030)
    Figure 51. U.S. Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 52. Canada Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 53. Europe Hexadecanamide Sales Market Share by Type (2019-2030)
    Figure 54. Europe Hexadecanamide Revenue Market Share by Type (2019-2030)
    Figure 55. Europe Hexadecanamide Sales Market Share by Application (2019-2030)
    Figure 56. Europe Hexadecanamide Revenue Market Share by Application (2019-2030)
    Figure 57. Europe Hexadecanamide Revenue Share by Country (2019-2030)
    Figure 58. Europe Hexadecanamide Sales Share by Country (2019-2030)
    Figure 59. Germany Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 60. France Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 61. U.K. Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 62. Italy Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 63. Russia Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 64. China Hexadecanamide Sales Market Share by Type (2019-2030)
    Figure 65. China Hexadecanamide Revenue Market Share by Type (2019-2030)
    Figure 66. China Hexadecanamide Sales Market Share by Application (2019-2030)
    Figure 67. China Hexadecanamide Revenue Market Share by Application (2019-2030)
    Figure 68. Asia Hexadecanamide Sales Market Share by Type (2019-2030)
    Figure 69. Asia Hexadecanamide Revenue Market Share by Type (2019-2030)
    Figure 70. Asia Hexadecanamide Sales Market Share by Application (2019-2030)
    Figure 71. Asia Hexadecanamide Revenue Market Share by Application (2019-2030)
    Figure 72. Asia Hexadecanamide Revenue Share by Region (2019-2030)
    Figure 73. Asia Hexadecanamide Sales Share by Region (2019-2030)
    Figure 74. Japan Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 75. South Korea Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 76. China Taiwan Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 77. Southeast Asia Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 78. India Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 79. Middle East, Africa and Latin America Hexadecanamide Sales Market Share by Type (2019-2030)
    Figure 80. Middle East, Africa and Latin America Hexadecanamide Revenue Market Share by Type (2019-2030)
    Figure 81. Middle East, Africa and Latin America Hexadecanamide Sales Market Share by Application (2019-2030)
    Figure 82. Middle East, Africa and Latin America Hexadecanamide Revenue Market Share by Application (2019-2030)
    Figure 83. Middle East, Africa and Latin America Hexadecanamide Revenue Share by Country (2019-2030)
    Figure 84. Middle East, Africa and Latin America Hexadecanamide Sales Share by Country (2019-2030)
    Figure 85. Brazil Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 86. Mexico Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 87. Turkey Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 88. Israel Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 89. GCC Countries Hexadecanamide Revenue (2019-2030) & (US$ Million)
    Figure 90. Hexadecanamide Value Chain
    Figure 91. Hexadecanamide Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed